Subscribe To
Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's...
February 23, 2022, 9:10 am
Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's...
February 23, 2022, 9:10 am
Algernon pharmaceuticals begins manufacturing repirinast and launches new chronic kidney disease research program
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) revealed that it has awarded a contract to China's...
February 23, 2022, 9:10 am
Lumos pharma to report full year 2021 financial results and host conference call on march 10, 2022
AUSTIN, Texas, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmac...
February 23, 2022, 9:00 am
Lumos pharma to report full year 2021 financial results and host conference call on march 10, 2022
AUSTIN, Texas, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmac...
February 23, 2022, 9:00 am
Lumos pharma to report full year 2021 financial results and host conference call on march 10, 2022
AUSTIN, Texas, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmac...
February 23, 2022, 9:00 am
Intercept to announce fourth quarter and full year 2021 financial results on march 2, 2022
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Intercept pharmaceuticals, Inc. (Nasdaq:ICPT), a bio...
February 23, 2022, 8:49 am
Intercept to announce fourth quarter and full year 2021 financial results on march 2, 2022
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Intercept pharmaceuticals, Inc. (Nasdaq:ICPT), a bio...
February 23, 2022, 8:49 am
Intercept to announce fourth quarter and full year 2021 financial results on march 2, 2022
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Intercept pharmaceuticals, Inc. (Nasdaq:ICPT), a bio...
February 23, 2022, 8:49 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Pfizer stock is ready to be added to your portfolio
pharmaceutical giant Pfizer (NYSE: PFE) stock had a blowout Q4 2021 quarter, but shares are pulling bac...
February 23, 2022, 3:00 am
Pfizer stock is ready to be added to your portfolio
pharmaceutical giant Pfizer (NYSE: PFE) stock had a blowout Q4 2021 quarter, but shares are pulling bac...
February 23, 2022, 3:00 am
Pfizer stock is ready to be added to your portfolio
pharmaceutical giant Pfizer (NYSE: PFE) stock had a blowout Q4 2021 quarter, but shares are pulling bac...
February 23, 2022, 3:00 am
Agios pharmaceuticals with fda approval is a buy
Agios pharmaceuticals With FDA Approval Is A Buy...
February 23, 2022, 12:28 am
Agios pharmaceuticals with fda approval is a buy
Agios pharmaceuticals With FDA Approval Is A Buy...
February 23, 2022, 12:28 am
Agios pharmaceuticals with fda approval is a buy
Agios pharmaceuticals With FDA Approval Is A Buy...
February 23, 2022, 12:28 am
Cara therapeutics to announce fourth quarter and full year 2021 financial results on march 1, 2022
STAMFORD, Conn., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage bio...
February 22, 2022, 4:01 pm
Cara therapeutics to announce fourth quarter and full year 2021 financial results on march 1, 2022
STAMFORD, Conn., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage bio...
February 22, 2022, 4:01 pm